《滬深兩市》上證全日近高收 醫藥股上揚 茅臺走弱
內地昨日(30日)新增本土確診病例166例,西安佔161例。人行今日開展1,000億元7天期逆回購操作,單日淨回籠900億元。人民幣兌美元中間價今下調83點。上月製造業PMI、非製造業PMI均勝預期,上證深成高開後反覆向好,上證近高收市。
上證高見3,642,全日升20點或0.6%,近高收報3,639點;深成指升61點或0.4%,收報14,857點;滬深300指數升18點或0.4%,收報4,940點;創業板指數全日近平收報3,322點,成交2,393億元。上證深成全日成交分別爲4,335億元及6,267億元。
中資金融股偏軟,工行(601398.SH)、建行(601939.SH)均跌0.2%。
綠電股上揚,西昌電力(600795.SH)漲停。國電電力(600795.SH)揚9.3%。華能國際(600011.SH)升4%。
首批包括上海、廣東等七個國家中醫藥綜合改革示範區獲準建設。國家醫保局、國家中醫藥管理局公佈,將適宜的中藥和中醫醫療服務項目納入醫保支付範圍,消息刺激醫藥股造好,同仁堂(600085.SH)、華潤三九(000999.SZ)、華森製藥(002907.SZ)漲停。
寧德時代(300750.SZ)擬斥不逾240億元擴建四川宜賓電池製造基地,股價高開低走跌0.3%。貴州茅臺(600519.SH)低開低走跌1.2%。(ta/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.